pillbase.ru

Constella

Active substance: linaclotide

linaclotide

Centralised EU authorisationActive

Marketing holder: AbbVie Deutschland GmbH & Co. KG

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Линзелакс®-Про
    капсулы, 145 мкг (original in Russian, GRLS)
    ЛП-№(015557)-(РГ-RU)
    Общество с ограниченной ответственностью "ПРОМОМЕД РУС" (ООО "ПРОМОМЕД РУС")
US 3
  • Linzess
    CAPSULE, GELATIN COATED · LINACLOTIDE 145 ug/1
    0456-1201
    Allergan, Inc.
  • Linzess
    CAPSULE, GELATIN COATED · LINACLOTIDE 72 ug/1
    0456-1203
    Allergan, Inc.
  • Linzess
    CAPSULE, GELATIN COATED · LINACLOTIDE 290 ug/1
    0456-1202
    Allergan, Inc.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-ef51-70b0-9232-f74f781a38d6;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12092-9a47-7608-8253-5a83a3271e46,01a12099-a942-7f71-810b-0a6d3e99a0aa,01a1209b-f10c-729b-b972-e891fa97e80f;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002490
Registration status
Active
ATC code
A06AX04
Sources
  • product · EMA · EMEA/H/C/002490 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002490 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002490 · Verified 2026-10-09